Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.4M | $80.0M | $250.0M | $40.9M | $37.4M | $171.1M | $104.4M | $7.6M | $10.1M | $14.2M | $17.3M | — |
| Research & development | $134.7M | $127.4M | $92.2M | $60.8M | $73.8M | $108.8M | $119.7M | $64.9M | $62.3M | $42.2M | $27.7M | $8.9M |
| Operating expenses | $172.2M | $163.3M | $128.0M | $91.7M | $111.0M | $143.7M | $156.1M | $98.7M | $82.0M | $55.5M | $37.6M | $14.4M |
| Operating income | −$131.8M | −$83.3M | $122.0M | −$50.8M | −$73.6M | $27.4M | −$51.7M | −$91.1M | −$71.9M | −$41.3M | −$20.3M | −$14.4M |
| Net income | −$119.7M | −$65.0M | $132.3M | −$46.4M | −$71.2M | $36.7M | −$43.6M | −$88.3M | −$70.7M | −$40.2M | −$29.7M | −$16.3M |
| Basic EPSper diluted share | -$2.04 | -$1.13 | $3.08 | -$1.21 | -$1.89 | $0.99 | -$1.21 | -$2.75 | -$2.64 | -$1.59 | $9.14 | $27.83 |
| Diluted EPSper diluted share | -$2.04 | -$1.13 | $2.97 | -$1.21 | -$1.89 | $0.98 | -$1.21 | -$2.75 | -$2.64 | -$1.59 | $9.14 | $27.83 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 2, 2026Form 4 · 10b5-1 | Sandrock AlfredPresident and CEO | SellCommon Stock | 11.5K | $3.87 | $44.5K | 472.5K |
| Feb 24, 2026Form 4 · 10b5-1 | Swartz RobinCOO & CBO | SellCommon Stock | 6.5K | $3.77 | $24.3K | 199.7K |
| Feb 24, 2026Form 4 · 10b5-1 | Sandrock AlfredPresident and CEO | SellCommon Stock | 14.2K | $3.79 | $53.8K | 484.1K |
| Feb 24, 2026Form 4 · 10b5-1 | Jorgensen Nathan D.Chief Financial Officer | SellCommon Stock | 4.7K | $3.77 | $17.6K | 151.4K |
| Feb 24, 2026Form 4 · 10b5-1 | Carter Todd AlfredChief Scientific Officer | SellCommon Stock | 4.2K | $3.76 | $15.7K | 145.7K |